2018
DOI: 10.1080/03014460.2018.1523461
|View full text |Cite
|
Sign up to set email alerts
|

Early menarche and premature natural menopause in Indonesia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
3
0
3

Year Published

2020
2020
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 30 publications
1
3
0
3
Order By: Relevance
“…3) whereby germline mutation burdens may be plateaued in the prepubertal years, with the establishment of adult germline mutation accumulation rates occurring sometime during adolescence, perhaps triggered by the onset of puberty. This model is consistent with previous reports suggesting that later puberty is associated with longer lifespans [29][30][31] , reduced cancer risks 32 , and later menopause [33][34][35][36] , as would be expected if puberty triggers a resumption of mutation accumulation, and consequently ageing, in both germline and somatic tissues.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…3) whereby germline mutation burdens may be plateaued in the prepubertal years, with the establishment of adult germline mutation accumulation rates occurring sometime during adolescence, perhaps triggered by the onset of puberty. This model is consistent with previous reports suggesting that later puberty is associated with longer lifespans [29][30][31] , reduced cancer risks 32 , and later menopause [33][34][35][36] , as would be expected if puberty triggers a resumption of mutation accumulation, and consequently ageing, in both germline and somatic tissues.…”
Section: Discussionsupporting
confidence: 92%
“…Developmental deficiency of the GH/IGF-1 axis in dwarf mice keeps IGF-1 levels in blood low, prevents the normal decline in DNA repair of adulthood, and significantly extends lifespan 28 . Also, polygenic risk scores for later onset of puberty in humans are associated with longer lifespans in both sexes 29 ; and later puberty is associated with decreased all-cause mortality in women 30,31 , reduced risk of cancer in both sexes 32 , and later menopause [33][34][35][36] . All of these associations are expected if mutation accumulation rates rise after puberty and contribute to both systemic and reproductive ageing.…”
mentioning
confidence: 99%
“…27 However, previous studies in both HICs and LMICs have showed moderate-to-high correlation (r=0.66-0.83) when comparing self-reported age earlier and later on in life. 28 One study based in Uganda triangulated the information obtained from the DHS and concluded that the DHS were very close to other studies on settings similar to the one being studied. The author went as far as saying that the quality of these data in LMICs might even be better than in HICs as the event is often of great cultural significance and therefore more likely to be remembered.…”
Section: Data Availability and Data Qualitymentioning
confidence: 75%
“…Esta técnica de medicina alternativa proporciona estimulación sensorial especializada que se transmite a través de las vías neuronales sensoriales. 14,15 Para comprender bien sus funciones específicas se necesita un análisis de la neuroanatomía, neurofisiología y neurofarmacología,…”
Section: At E R I a L E S Y M é To D O Sunclassified
“…[4][5][6][7][8][9] Si bien todos los síntomas a menudo anuncian la aparición de la menopausia, muchos otros órganos y sistemas se ven afectados como consecuencia de la disminución de las concentraciones del estrógeno. [10][11][12][13] Dado que casi todos los tejidos (huesos, sistema cardiovascular y nervioso central, tracto gastrointestinal y urogenital) expresan receptores de estrógenos, se afectan de alguna manera por la disminución, 14 aunque también se ven comprometidos por el envejecimiento. 15 No todas las mujeres que manifiestan síntomas menopaúsicos pueden utilizar la terapia hormonal de reemplazo, pues hay contraindicaciones médicas (antecedentes de cáncer de mama y/o endometrio, tromboembolismo venoso activo, hepatopatía grave) o incluso la falta de consentimiento del paciente para este tipo de tratamiento (miedo a desarrollar cáncer, a subir de peso e intolerancia).…”
unclassified